BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation: Our Bureau, Mumbai Saturday, February 22, 2025, 08:00 Hrs [IST] Bio Asia, Asia's premier life sc ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

It has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have added about 8.9% in that time frame, outperforming the S&P 500. Will the recent positive trend ...